Bovine Blood Plasma Derivatives Market 2019 | Size, Merger and Share | By Products, Applications and End Users Overview Forecast to 2026
Bovine blood plasma derivatives are a rich source of proteins that are extracted from the blood plasma of bovine animals by using physicochemical or other fractionation processes. Bovine blood plasma encompasses anti-inhibitor coagulation complex (AICC), factor VIII and IX concentrate, albumin, and immunoglobulins such as Rh immune globulin, anti-thrombin III concentrate, and alpha 1-proteinase inhibitor concentrate. Moreover, plasma derivatives are basically used for sequence analysis, protein structure analysis, and biochemical research.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/2432
Growing usage of bovine blood plasma derivatives in biopharmaceutical companies for various applications such as cell culture technique, biotechnology, and research and development is projected to fuel the market growth of bovine blood plasma derivatives. For Instance, in November 2018, Wageningen University initiated the preclinical trial for bovine plasma protein powder to assess the protein digestion kinetics and protection of the epithelial barriers such as other markers for identification of gastrointestinal health, metabolic health, and vascular health, and satiating properties.
Market – Restraints
The availability of alternatives to bovine blood plasma derivatives is projected to hinder the market growth. For Instance, in April 2015, Rocky Mountain Biologicals, Inc. – a life science and bioprocessing company — launched a high-performance Fetal Bovine Serum alternative — Fetalgro. Fetalgro is a proprietary blend of a calf serum base and proprietary additives that match the Fetal Bovine Serum’s (FBS) cell growth capabilities in CHO, MRC-5, Vero, and a wide range of other cell lines.
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2432
On the basis of region, the global bovine plasma derivatives market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is projected to experience significant market growth over the forecast period due to the increasing focus of key players in the region on adopting merger and acquisition strategies in order to expand their geographical presence, which in turn is expected to contribute to regional market growth. For Instance, in August 2018, LAMPIRE Biological Laboratories acquired 180+ acre corporate dairy farms located adjacent to the existing corporate farm facilities in Bedford County, Pennsylvania. The acquisition has been made to expand its operations and establishments in the western part of Pennsylvania. By this acquisition, LAMPIRE Biological Laboratories intended to offer valuable biological raw materials to diagnostic and research companies around the world.
Furthermore, Asia Pacific is projected to witness significant growth in the market over the forecast period and this can be attributed to rising government initiatives and approvals to export products such as cattle protein and serum. For Instance, in June 2017, the Government of China approved formal access for bovine blood products from New Zealand in the market in China. The approval was passed by the General Administration of Quality Supervision, Inspection, and Quarantine of the People’s Republic of China. Under the approval, the Ministry for Primary Industries New Zealand gave access to sixteen manufacturing plants to export products such as cattle protein and serum to China.
Key players operating in the global bovine blood plasma derivatives market include Proliant Inc., Bovogen Biologicals Pty Ltd., LAMPIRE Biological Laboratories, Inc., Rocky Mountain Biologicals Inc., Thermo Fisher Scientific, Inc., Sigma-Aldrich Co. (Merck KGaA), Kraeber & Co GmbH, Auckland BioSciences Ltd., and Lake Immunogenics, Inc.
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/2432
By Derivatives Type
- Serum Albumin
- Fetal Bovine Serum
- New Born Calf Serum
- Pharmaceutical Industry
- Diagnostics Industry
- Cell Culture/ Biotechnology
- Research and Development
- Food Industry
- Cosmetic Industry
- North America
- Asia Pacific
- Latin America
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire